Deep Track Capital’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-290,844
Closed -$823K 72
2022
Q2
$823K Sell
290,844
-737,671
-72% -$2.67M 0.05% 50
2022
Q1
$5.5M Sell
1,028,515
-71,485
-6% -$405K 0.35% 44
2021
Q4
$8.22M Buy
+1,100,000
New +$9.18M 0.58% 43

Other funds holding ATYR

Deep Track Capital's ATYR Position: Q3 2022 in Review

Deep Track Capital sold out of aTyr Pharma (ATYR) in Q3 2022, closing a stake of 290,844 shares — an estimated $823K sold.

Deep Track Capital first reported a position in ATYR in Q4 2021 and held it in 3 quarters. The position peaked at $8.22M in Q4 2021. 33 funds tracked by Wall St. Rank hold ATYR as of Q3 2022.

  • Deep Track Capital reported no remaining aTyr Pharma position as of Q3 2022 after selling out during the quarter.
  • Deep Track Capital sold 290,844 aTyr Pharma shares in Q3 2022, an estimated $823K.
  • Deep Track Capital first reported a position in aTyr Pharma in Q4 2021 and held it in 3 quarters.
  • Deep Track Capital's aTyr Pharma position peaked at $8.22M in Q4 2021.
  • 33 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2022.

Based on Deep Track Capital's 13F filing for Q3 2022, filed 14 Nov 2022.